| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3292957 | Gastroenterology | 2012 | 12 Pages |
Abstract
In a small randomized controlled trial, a 12-month course of enoxaparin was safe and effective in preventing PVT in patients with cirrhosis and a Child-Pugh score of 7-10. Enoxaparin appeared to delay the occurrence of hepatic decompensation and to improve survival. www.isrctn.>org: ISRCTN32383354; www.clinicaltrialsregister.eu: EudraCT2007-007890-22.
Keywords
INRI-FABPsCD14RCTRDNASBPPVTIL-6Ribosomal DNARandomized controlled trialBacterial translocationinterleukin 6portal vein thrombosisAnticoagulant therapyProphylaxisSoluble CD14Model for End-Stage Liver Diseasehazard ratioInternational Normalized Ratiopolymerase chain reactionPCRPortal hypertensionspontaneous bacterial peritonitisMELD
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Erica Villa, Calogero Cammà , Marco Marietta, Monica Luongo, Rosina Critelli, Stefano Colopi, Cristina Tata, Ramona Zecchini, Stefano Gitto, Salvatore Petta, Barbara Lei, Veronica Bernabucci, Ranka Vukotic, Nicola De Maria, Filippo Schepis,